Analysis of Lung Cancer Tissue With Spatial Frequency Domain Imaging
Part of paid clinical trials in Orange, California.
- Sponsor
- University of California, Irvine
- Study ID
- NCT06549088
- Status
- Enrolling By Invitation
Conditions
- Cancer, Lung
- Lung Diseases
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Spatial Frequency Domain Imaging — DEVICEResected lung tissue will be removed from the surgical field and labeled with sutures per standard of care. The specimen will then be immediately analyzed using two SFDI devices in the operating room using sterile technique. Each specimen will be recorded up to three times to ensure at least one high fidelity recording is captured. The SFDI data will be analyzed and compared to the official pathology report from the electronic medical record.
Study Details
This study investigates if a new imaging device can detect different types of lung tissue using spatial frequency domain imaging (SFDI). Specifically, this study aims to detect lung nodules within normal lung tissue and determine if lung nodules are cancerous. Patients who have confirmed or suspected lung nodules and who are undergoing resection of those nodules will be recruited for the study. Study participants will undergo standard of care lung nodule resection in the operating room, and the resected specimen will be imaged using the SFDI device immediately after removal from the surgical field. The data captured from the SFDI images will then be compared to the pathology findings to identify optical properties of normal and cancerous lung tissue. Because the intervention is conducted on resected biospecimens, this study yields minimal risk to participants.
Key Dates
- Start date
- Aug 7, 2023
- Status verified
- Aug 2024
- Primary completion
- Aug 1, 2025
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
Primary Outcome Measure
Markers of native lung parenchyma [ Time Frame: May 7, 2023 to December 31, 2026 ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, Irvine Medical Center | Orange | California | 92868 | - |
Find similar trials in Orange, CA
Related Studies
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- American Lung Association (ALA) Lung Health CohortRecruiting · Johns Hopkins University · Birmingham, Alabama
- BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)PHASE2 · Recruiting · Dana-Farber Cancer Institute · Stanford, California